Back to Test Directory

TL98 : OnkoSight Advanced NGS MDS Panel

INFORMATION:

Alternate Name:
OSA NGS MDS
Methodology:
Genotyping by Next Generation Sequencing
Clinical Utility:
Tumor sequencing by NGS detecting mutations in 18 genes associated with MDS. Mutations often have prognostic significance, may confer resistance to FDA approved therapies, or may qualify patients for late-stage clinical trials. Gene content: ASXL1 BCOR CBL DNMT3A ETV6 EZH2 JAK2 KRAS NRAS PTPN11 RUNX1 SETBP1 SF3B1 SRSF2 TET2 TP53 U2AF1 ZRSR2

ORDERING:

Test Code:
TL98-8
Turnaround Time:
10 DAYS
Preferred Specimen:
2 mL Peripheral Blood - Lavender Top
Collection:
Container Qty Temp Stability
Peripheral Blood - Lavender Top 1 Room Temp 30 DAYS
Collection Instructions:
LPB: Fill tube, invert gently 5-6 times, label with patient's name
Storage Transport Instructions:
BML/BMG: Place bone marrow into tube, label with patient's name and send in provided kit.
LPB/GPB: Place peripheral blood into tube, label with patient's name and send in provided kit.
Alternative specimen: Extracted DNA is acceptable, providing that the isolation of nucleic acid occurs in a CLIA-certified laboratory or a laboratory meeting equivalent requirements as determined by CMS and/or the CAP.
Storage/Transport Instruction: Specimen can be either RT or refrigerated
Specimen Comment:
Decalcified specimens are not recommended for NGS testing.
Alternative Specimen:
Peripheral Blood - Green Top, Bone Marrow - Green Top, Bone Marrow - Lavender Top, Eppendorf tube, Formalin-fixed, Paraffin-embedded Tissue, Unstained Slide

Billing:

CPT Codes:
81450 x 1

CPT Code Disclaimer

CPT codes provided are for informational purposes only. Accuracy of CPT presented should be validated prior to consideration for billing.
CPT coding is the sole responsibility of the billing party. Please direct any questions regarding CPT coding to the payer being billed.